Clinical trials - Press Releases

Date	Title	Company
30-Jan-2020	Bionetix, ProQinase, and Mercachemsyncom Announce a Joint Research Project from Target Identification to Clinical Study	Bionetix, ProQinase, and Mercachemsyncom
29-Jan-2020	Most innovative cancer drugs facing delays in reaching patients	The Institute of Cancer Research
29-Jan-2020	Sanofi : FDA accepts for priority review Dupixent® (dupilumab) for children aged 6 to 11 years with moderate-to-severe atopic dermatitis	Sanofi
29-Jan-2020	Kite, a Gilead Company, to present latest cell therapy research at the 2nd European CAR T Cell Meeting, Sitges, Spain	Gilead
29-Jan-2020	SAGA Diagnostics Extends its Collaboration with Servier to Use Ultrasensitive SAGAsafe® Technology in Cancer Clinical Trials	LUND
29-Jan-2020	Immutep activities report - late-stage Phase IIb metastatic breast cancer results ETA, TACTI-002 results ETA	Immutep Limited
29-Jan-2020	Signant Health Enhances Audit Trail Reporting CapabiliTrialMax® to Improve eCOA Data Integrity Monitoring	Signant Health
28-Jan-2020	Registration Opens for SMi’s 20th Annual Pain Therapeutics Conference	SMi Group
24-Jan-2020	Dupixent®▼ (dupilumab), accepted for restricted use within NHS Wales for the treatment of moderate to severe atopic dermatitis in adolescents aged 12 years and over1	Sanofi
24-Jan-2020	Dupixent®▼ (dupilumab) available to treat adolescents with moderate to severe atopic dermatitis in Scotland1	Sanofi
24-Jan-2020	Sanofi Completes Acquisition of Synthorx, Inc.	Sanofi
24-Jan-2020	Johnson & Johnson Announces $250 Million Commitment to Support Frontline Health Workers, Reaching 100 Million People by 2030	Davos
24-Jan-2020	Genmab Announces 2019 Net Sales Figures for DARZALEX® (daratumumab) and Achievement of USD 150 Million Sales Milestone in DARZALEX Collaboration with Janssen	Genmab
24-Jan-2020	Global Contract Research Organisation Expands Services with Oracle Argus Cloud	PharSafer
24-Jan-2020	Growing AXON Brighton Team Relocates to Larger New Office	AXON
24-Jan-2020	iOnctura raises EUR 15 million in Series A financing to progress its pipeline into clinical development	iOnctura
24-Jan-2020	European CNS specialist Neuraxpharm strengthens expansion into Austrian market with acquisition of easypharm	Neuraxpharm Group
24-Jan-2020	Risdiplam (RG7916) Pivotal FIREFISH Study Demonstrated Statistically Significant Improvement in Infants with Type 1 Spinal Muscular Atrophy	PTC Therapeutics, Inc
24-Jan-2020	Autolus Announces Proposed Public Offering in the United States	Autolus Therapeutics plc
24-Jan-2020	Autolus Announces Pricing of Public Offering	Autolus Therapeutics plc